Press Release
Press Release
North America accounts for a considerable share of the oral antibiotics industry owing to the robust healthcare sector in the region. The wide accessibility to quality healthcare in the United States and Canada is surging the demand for oral antibiotics to treat various health-related issues, driving the market growth. In addition, the increasing research and development (R&D) activities to develop innovative and advanced oral antibiotics is driving the market growth. The Asia Pacific region is witnessing robust growth owing to the rising manufacturing of oral antibiotics in countries like India and China, among others. Furthermore, as the prevalence of infectious issues such as tuberculosis and influenza is surging, the market for oral antibiotics is growing significantly. Moreover, the increasing focus to address the emerging issue of antibiotic resistance is projected to provide lucrative growth opportunities to the market growth in the forecast period.
GlaxoSmithKline plc (NYSE: GSK), one of the leading companies in the market, announced in October 2019 that it had initiated a Phase III clinical program to investigate the efficacy of gepotidacin in patients with urogenital gonorrhoea (GC) and uncomplicated urinary tract infections (UTI). The phase III program comprised two studies- to compare gepotidacin to ceftriaxone and azithromycin in urogenital gonorrhoea and compare gepotidacin to nitrofurantoin for urinary tract infection. The novel oral antibiotic is developed with a public-private relationship with the company and the Biomedical Advanced Research and Development Authority (BARDA) and Defense Threat Reduction Agency (DTRA) of the United States. The clinical trial of oral antibiotics is an important step to support the development of various antibiotics to fight bioterrorism and antibiotic resistance. As a result, such clinical trials are augmenting the market's growth.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The major players in the global oral antibiotics market are GlaxoSmithKline plc, Abbott Laboratories, Allergan Plc, Hoffmann-La Roche Ltd., and Pfizer Inc., among others. The comprehensive report by EMR looks into the market share, capacity, and latest developments like mergers and acquisitions, plant turnarounds, and capacity expansions of the major players.
Expert Market Research (EMR) is a leading market research and business intelligence company, ensuring its clients remain at the vanguard of their industries by providing them with exhaustive and actionable market data through its syndicated and custom market reports, covering over 15 major industry domains. The company's expansive and ever-growing database of reports, which are constantly updated, includes reports from industry verticals like chemicals and materials, food and beverages, energy and mining, technology and media, consumer goods, pharmaceuticals, agriculture, and packaging.
EMR leverages its state-of-the-art technological and analytical tools, along with the expertise of its highly skilled team of over 100 analysts and more than 3000 consultants, to help its clients, ranging from Fortune 1000 companies to small and medium-sized enterprises, easily grasp the expansive industry data and help them in formulating market and business strategies, which ensure that they remain ahead of the curve.
Expert Market Research
Website: www.expertmarketresearch.com
Email: sales@expertmarketresearch.com
US & Canada Phone no: +1-415-325-5166
UK Phone no: +44-702-402-5790
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.